Boehringer Ingelheim Obtains Novel Preclinical Oncology Program From Accent Therapeutics
ReutersOct 8, 2025 12:19 PM
Oct 8 (Reuters) -
BOEHRINGER INGELHEIM OBTAINS NOVEL PRECLINICAL ONCOLOGY PROGRAM FROM ACCENT THERAPEUTICS
BOEHRINGER INGELHEIM: ACCENT THERAPEUTICS TO GET UPFRONT PAYMENT AND ENTITLED TO SUCCESS-BASED PRECLINICAL MILESTONE PAYMENTS
Further company coverage: [ ]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
BOE Seen Poised for Further Rate Cuts.Sterling Seen Extending Slide Against Dollar
TradingKey - UK Economy Shows Persistent Weakness as Construction Slump Deepens.The UK economy remains under pressure, with S&P Global’s latest purchasing managers’ index (PMI) released on the 6th showing that construction activity contracted for a ninth consecutive month in September.TradingKey
14 hours ago
FOMC October Meeting Minutes: How Should Investors Respond?
In the context of the U.S. government shutdown and a period of limited economic data, the Federal Reserve’s release of its latest monetary policy meeting minutes and officials’ statements on 8 October will be particularly significant.TradingKey
Tue, Oct 7
Is the UK Economy Headed for Collapse? Will Assets Face a "Triple Slump" in Stocks, Exchange Rates, and Bonds?
Many investors and analysts assert that the UK economy is on the brink of collapse, with its assets facing a "triple slump" across stocks, foreign exchange, and bonds.TradingKey
Mon, Oct 6
U.S. Government Shutdown Commentary: Is a Stock Market Crash Imminent? Will Gold Prices Continue to Surge?
TradingKey - On 1 October 2025, the U.S. federal government officially entered a shutdown, impacting various asset classes. This article analyses two key markets most affected—U.S. equities and gold—to help investors identify potential opportunities.TradingKey
Wed, Oct 1
Broadcom Q3 FY2025 Earnings Review: AI Surge and VMware Synergy Fuel Record Performance
TradingKey - Broadcom Inc. (NASDAQ: AVGO) delivered a strong fiscal Q3 2025, with results driven by AI networking strength and continued VMware integration. Revenue and EPS both topped expectations, reinforcing the company’s role as an essential player in the AI infrastructure buildout.TradingKey
Fri, Sep 5
